Can Bromocriptine be used as a treatment option for hormone-sensitive cancers and what evidence supports its efficacy in such cases?
Share
Sign Up to our social questions and Answers Engine to ask questions, answer people’s questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Bromocriptine has been studied in hormone-sensitive cancers such as breast and prostate cancer due to its prolactin-lowering effects, which might impede cancerous growth in prolactin-responsive tissues. However, it is not a standard treatment, and more research is needed to establish its efficacy.
Bromocriptine has shown limited efficacy in hormone-sensitive cancers like breast and prostate. It inhibits prolactin, potentially reducing tumor progression.